FDA Inspection
Wells Pharmacy, IncWells Pharmacy, Inc – FDA Inspection, Apr 25, 2025
Record Details
This FDA Inspection record concerns Wells Pharmacy, Inc, with an inspection on April 25, 2025, issued by the New Orleans District Office, covering human drugs.
View Company Profile
ID · 470b78d1-875f-4621-bd24-e2f763015eb7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1271216
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.167(c)Controlled release dosage form testing
- 21 CFR 211.94(b)Protection from external factors
- FDCA 503B(a)(10)(A)Drug product labels, fails to include
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Wells Pharmacy, Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| April 9, 2026 | Not classified | New Orleans District Office | Drug Quality Assurance |
| January 28, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 27, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 20, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Wells Pharmacy, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.